Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levo Phencynonate Hydrochloride for Prevention of Seasickness
NCT02241629Phase 2Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Aug 2014
- Primary completion
- Dec 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levophencynonate hydrochloride in motion sickness (3 arms), sponsored by Sihuan Pharmaceutical. Primary endpoint: symptoms of seasickness at 2 hours. Started Aug 2014; status: completed.
02
Drugs
levophencynonate hydrochloride
03
Conditions
motion sickness
Beyond the preview
Go deeper on NCT02241629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241629.